Agomab Therapeutics
AGMB
#7208
Rank
S$0.66 B
Marketcap
S$13.55
Share price
1.81%
Change (1 day)
N/A
Change (1 year)

Agomab Therapeutics (AGMB) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$27.88 Million

According to Agomab Therapeutics 's latest financial reports the company's total liabilities are S$27.88 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Agomab Therapeutics - Total liabilities on balance sheet (from 2024 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$25.85 M-10.68%
2023-12-31S$28.94 M-42.08%
2022-12-31S$49.96 M-21.61%
2021-12-31S$63.74 M